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INTRODUCTION 
Peripheral neuropathies are caused by dysfunction of peripheral 
motor, sensory and autonomic nerves.  
Alcoholic neuropathy is commonly seen neuropathy in general 
practice. Depending on the diagnostic criteria used, its frequency varies 
from 12.5% to 48.6% in chronic alcoholism (1). Covert alcoholism may 
only be uncovered by a focused history provided by family members.  
Alcoholic neuropathy commonly presents with sensory neuropathic 
symptoms like paresthesias and burning sensation over both feet with or 
without motor symptoms. 
A close association between alcoholic neuropathy and nutritional 
deficiency is well documented. The neuropathic picture of chronic 
alcoholism is essentially indistinguishable from thiamine deficiency. 
To some physicians, neuropathy is present only when symptoms or 
signs appear but others may diagnose alcoholic neuropathy based solely 
on electrophysiological, quantitative sensory testing or autonomic 
abnormalities.  
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In general, the diagnosis of a definite alcoholic neuropathy should 
be based on clinical symptoms, objective neurological signs and 
electrodiagnostic confirmation.  
This study was undertaken to analyse the clinic - 
electrophysiological correlation in patients with alcoholic peripheral 
neuropathy. 
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AIM OF THE STUDY 
1. To study and analyse the clinical symptomatology and signs of 
peripheral neuropathy in patients with alcoholism, using 
appropriate scoring system.  
2. To determine the correlation between clinical features and findings 
on nerve conduction studies.  
3. To analyse autonomic dysfunction in patients with alcoholic 
neuropathy. 
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REVIEW OF LITERATURE 
Introduction: 
 Although alcohol abuse and dependency are commonly called 
alcoholism, the text revision of the fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR) does not use the 
term because it lacks a precise definition.  
Alcohol dependence is defined in DSM-IV as repeated alcohol-
related difficulties in at least three of seven areas of functioning that 
cluster together over a 12-month period. Two of these seven items, 
withdrawal and tolerance, may have special importance as they are 
associated with a more severe clinical course.  
Alcohol abuse is defined as repetitive problems with alcohol in any 
one of four life areas - social, interpersonal, legal, and occupational - or 
repeated use in hazardous situations such as driving while intoxicated. If 
an individual is not alcohol dependent, he or she still may be given a 
diagnosis of alcohol abuse. 
About 50% of those with alcohol abuse continue to have alcohol 
problems 2 - 5 years later, but only 10% of these patients including 
adolescents - go on to develop alcohol dependence. 
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  Rates are generally similar in the United States, Canada, Germany, 
Australia, and the United Kingdom; tend to be lower in most 
Mediterranean countries, such as Italy, Greece, and Israel; and may be 
higher in Ireland, France, and Scandinavia. Even higher lifetime 
prevalence has been reported for most native cultures, including 
American Indians, Eskimos, Maori groups, and aboriginal tribes of 
Australia. These differences reflect both cultural and genetic influences, 
as described below. Lifetime risk for alcoholism among physicians is 
similar to that of the general population. 
Genetics: 
Approximately 60% of the risk for alcohol use disorders is 
attributed to genes, as indicated by the fourfold higher risk for alcohol 
abuse and dependence in children of alcoholics and a higher risk in 
identical twins as compared to fraternal twins of alcoholics (2). The 
genetic variations appear to operate primarily through intermediate 
characteristics that subsequently relate to the environment in altering the 
risk for heavy drinking and alcohol problems. 
Structure of Peripheral Nerves: 
The Peripheral Nervous System (PNS) includes all neuronal 
elements lying outside the pia mater of the spinal cord and brainstem with 
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the exception of cranial nerves - the optic nerves and olfactory bulbs, 
which are but special extensions of the brain (3). 
The peripheral nerve is a cable-like structure containing bundles of 
both unmyelinated and myelinated fibers and their supporting elements. 
The unmyelinated axons are surrounded only by the plasma membrane of 
a Schwann cell.  
The myelinated axons are engulfed by a Schwann cell that wraps 
around the axons multiple times, thereby insulating the axon with 
multiple layers of lipid-rich cell membrane. The myelinated axon is 
surrounded completely by myelin and Schwann cells except at regular 
gaps called the nodes of Ranvier, which measure approximately 1 μm in 
adults (4). 
The propagation of action potentials from one node of Ranvier to 
the next (salutatory conduction) is maintained by a thick myelin sheath 
with low capacitance and high resistance to electric current. 
Symptomatology (4): 
Motor system:  
Positive motor symptoms  Negative motor symptoms 
Cramps Weakness 
Twitching  Fatigue 
Myokymia Wasting 
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Tremor  
Sensory system: 
Positive sensory symptoms  Negative sensory symptoms 
Paresthesias Numbness 
Pins and needles Cotton wool sensation 
Burning sensation Foot deformities 
Tingling sensation Painless ulcerations 
Dysesthesias, Allodynia  
Tightness  
 
Autonomic Symptoms: 
Positive symptoms  Negative  symptoms 
Hyperhydrosis Orthostatic hypotension 
Diarrhea  Erectile dysfunction 
Gastroparesis - nausea, vomiting Anhydrosis 
 Constipation 
 
Classification of peripheral neuropathy: 
1. Based on histopathology (1) 
• Cell body (neuronopathy)  
Sensory Gangliopathy 
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Motor neuronopathy 
• Demyelinating  
• Axonal 
2. Time course (5) 
• Acute (< 1 mon) 
• Subacute  (1 - 6 mon) 
• Chronic  ( > 6 mon) 
• Longstanding heritable  
• Recurrent  
3. Fiber type involvement (5) 
• Motor Vs Sensory 
• Large Vs Small 
• Somatic Vs Autonomic 
4. Anatomical location (5) 
• Mononeuropathy 
• Plexopathy 
o Brachial plexopathy 
o Lumbar plexopathy 
o Sacral plexopathy 
• Radiculopathy (5) 
o Cervical radiculopathy 
o Thoracic radiculopathy 
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o Lumbosacral radiculopathy 
• Multiple mononeuropathy (mononeuropathy multiplex) 
• Polyneuropathy 
o Symmetrical polyneuropathy 
o Asymmetrical polyneuropathy 
• Polyradiculoneuropathy. 
• Distal symmetrical Polyneuropathy 
• Polyradiculopathy  
• Single Mononeuropathy 
• Multiple Mononeuropathies  
• Focal root, plexus, or nerve disorders  
 
Pathological Processes Involving Peripheral Nerves (6):  
Depends on pathological processes grouped into 
1. Wallerian degeneration 
2. Axonal degeneration 
3. Neuronal (perikaryal) degeneration or neuronopathy 
4. Segmental demyelination 
Most polyneuropathies are fairly symmetrical, but some are 
asymmetrical and may be confused with confluent mononeuropathy 
ma
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Neurological and Medical Complications of Alcohol Use (7):  
1. Alcohol intoxication (8) 
    Acute intoxication 
    Pathological intoxication (atypical, complicated, unusual) 
    Blackouts 
2.Alcohol withdrawal syndromes 
    Tremulousness 
    Alcoholic hallucinosis  
    Withdrawal seizures  
    Delirium tremens (9) 
3.Nutritional diseases due to alcohol abuse 
    Werniecke’s encephalopathy (10) 
Korsakoff syndrome (11) 
    Cerebellar degeneration 
  Neuropathy 
    Optic neuropathy 
    Pellagra 
4.Alcoholic disorders of uncertain pathogenesis (12) 
    Central pontine myelinolysis 
    Marchiafava-Bignami disease (13) 
    Fetal alcohol syndrome (14, 15)  
12 
 
       Alcoholic dementia (16) 
    Cortical atrophy (17, 18) 
Myopathy (19) 
 
5. Neurological complications due to systemic diseases 
Hepatic disease 
       Hepatic encephalopathy 
       Non-Wilsonian chronic hepatocerebral degeneration 
 Gastrointestinal diseases 
       Malabsorption syndromes 
    Postgastrectomy syndromes 
    Pancreatic encephalopathy 
 Cardiovascular diseases 
    Cardiomyopathy with potential cardiogenic emboli and storke 
    Arrhythmias and abnormal blood pressure leading to stroke 
Infectious disease, especially meningitis (especially pneumococcal and 
meningococcal) 
Hypothermia and hyperthermia 
Hypotension and hypertension 
Respiratory depression and associated hypoxia 
Electrolyte imbalances leading to acute confusional states and 
neurological signs and symptoms (20) 
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    Hypoglycaemia 
    Hyperglycaemia 
    Hyponatremia 
    Hypercalcemia 
    Hypomagnesaemia 
    Hypophosphatemia 
Trauma 
    Epidural, subdural, and intracerebral hematoma 
    Posttraumatic seizure disorders 
    Compressive neuropathies and brachial plexus injuries     
Posttraumatic symptomatic hydrocephalus     
Muscle crush injuries and compartmental syndromes 
 
Alcoholic neuropathy:  
Etiology: 
Direct toxic effect of alcohol and deficiency of thiamine and other 
B vitamins, caused by inadequate dietary intake, impaired absorption, and 
greater demand for thiamine to catalyze the metabolism of the alcohol are 
considered the major cause of polyneuropathy in alcoholic patients (22).  
Direct effects of alcohol and its metabolite: 
Role of acetaldehyde: 
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 Acetaldehyde reduces glutathione formation, impairment of 
mitochondrial electron transport chain, inhibition of DNA repair, and 
stimulation of immunologic reactivity which results in peripheral nerve 
dysfunction (23). 
 As figure 3 depicts, various mechanism at molecular level involved 
in the development of alcoholic neuropathy and neuropathic pain are 
1. Acetaldehyde induced oxidatine-nitrodative stress which results in 
overproduction of cytokines (24). 
2. Over-activation of protein kinase C. 
3. Role for ERK (Extracellular signal-regulated kinases) signalling 
(25). 
In a study by Zambelis et al. (2005), ethanol per se plays a major role 
in the development of neuropathy in alcoholics. 
 
2.  Role of thiamine in alcoholic neuropathy: 
 Victor and Adams (1961), Novak and Victor (1974) and Koike et 
al. compared the clinic pathologic features of thiamine deficiency 
neuropathy due to dietary imbalance in postgastrectomy patients and 
beriberi neuropathy and they concluded that both conditions are similar 
manifestations- sensory predominant neuropathy.  
 Subsequent electrophysiological studies by Ohnishi et al., 1980; 
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These studies lead to the the concept of alcoholic neuropathy, 
encompasses both direct neurotoxicity of ethanol or its metabolites and 
the concomitant effects of nutritional status, especially thiamine 
deficiency. 
 In a study by Koike et al., 2004, pure alcoholic neuropathic 
patients without thiamine deficiency had sub acute onset small fiber 
predominant painful neuropathy whereas thiamine deficiency patients had 
acute in onset motor predominant neuropathy.  
3. Role of nutritional status other than thiamine deficiency: 
 In a Danish study Behse and Buchthal et al, deficiency of B 
Vitamins other than thiamine deficiency may contribute in the 
development of alcoholic neuropathy. 
Clinical features: 
In chronic alcoholics, sensory symptoms commence in the feet and 
advance proximally in the gradual length-dependent manner associated 
with distal axonopathy. Eventually, legs to the knees and hands are 
involved (26). Numbness, tingling, or discomfort (hot and cold or burning 
sensations) in the toes is frequent initial complaints, followed by unsteady 
gait. 
Pain is widely held to be a hallmark of alcoholic neuropathy (27). 
Pain in alcoholic neuropathy is variable; it may be fleeting or persistent 
and can be mild and annoying or severe and disabling. Common 
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complaints are cold, boring, burning, sticking, or lightning-like sensations 
in the feet and distal legs.  
 
Cramping sensations in the legs are common, as is nocturnal 
allodynia evoked by rubbing the feet against bedclothes; symptomatic 
weakness is also reported. Autonomic symptoms or subtle evidence of 
autonomic dysfunction frequently are present from the beginning.   
Autonomic symptoms may be sudomotor (dry skin due to lack of 
sweating or excessive sweating in defined areas), pupillary (poor dark 
adaptation, sensitivity to bright lights), cardiovascular (postural 
lightheadedness, fainting), urinary (urgency, incontinence, dribbling), 
gastrointestinal (diarrhea, constipation, nausea, or vomiting), and sexual 
(erectile impotence and ejaculatory failure in men, loss of ability to reach 
sexual climax in women). Early physical findings are symmetrically 
impaired vibratory, position, touch, thermal, and pain senses in the distal 
lower limbs that slowly move proximally over time; impaired vibratory 
sense is often a heralding sign. Impairment of small-fiber sensation may 
be profound, with ulceration of the soles and joint deformities (28). 
Weakness, if present, is mild and distal; wasting of the extensor 
digitorum brevis is occasionally present. 
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Electrodiagnostic Studies: 
It is helpful to follow a decision-making pathway based initially on 
the overall pattern of distribution of deficits, followed by the 
electrophysiological findings, and finally the clinical course.  
Electrodiagnostic studies, carefully performed and directed to the 
particular clinical situation, play a key role in the evaluation by  
(1) Confirming the presence of neuropathy,  
(2) Precisely locating focal nerve lesions, and 
(3) Giving information as to the nature of the underlying nerve 
pathology (29) (Gooch and Weimer, 2007; Wilbourn, A.J., 2002).  
Nerve Conduction Studies  
Demyelination is present if motor and sensory nerve conduction 
velocities (NCVs) are reduced to less than 70% of the lower limits of 
normal, with relative preservation of response amplitudes (30).  
Temporal dispersion of compound muscle action potentials, motor 
conduction block, marked prolongation of distal motor and F-wave 
latencies are all features consistent with acquired demyelination (31). 
Axonopathies result in low-amplitude sensory nerve action 
potentials and compound muscle action potentials, but they affect distal 
latencies and conduction velocities only slightly.  
Alcoholic neuropathy had axonal changes in the NCS, 
predominantly involving sensory nerves of lower limbs which was 
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observed by various investigators like Coers and Hildebrand et al 1965; 
Walsh and McLeod, 1970; and Blackstock et al., 1972. 
 
Autonomic function tests (32): 
A. Test for cardiovascular autonomic regulation: 
1. Cardiovagal heart rate tests 
Heart rate response to deep breathing 
Valsalva ratio 
Heart rate response to standing 
2Adrenergic function tests 
Blood pressure and heart rate response to standing/tilt 
Blood pressure responses to sustained hand grip 
Blood pressure responses to valsava manoeuvre. 
3. R-R interval variation studies reflecting sympathovagal balance  
B. Tests for sudomotor and thermoregulatory function 
Quantitative Sudomotor Axon Reflex Test 
Thermoregulatory sweat test 
Sympathetic skin response 
Sweat imprint 
C. Test for genitourinary autonomic regulation 
21 
 
D. Tests for gastrointestinal autonomic regulation 
 
Treatment: 
Consists of management alcoholism & its rehabilitation and treatment of 
neuropathy 
Principal therapy (33): 
Abstinence from alcohol, 
Addiction counseling,  
Nutritionally balanced diet. 
Supplementation with thiamine and other B vitamins is important. 
In patients with significant gastrointestinal symptoms, parenteral vitamin 
treatment is initially required. Improvement in the polyneuropathy may 
be very slow because it requires axonal regeneration 
Rehabilitation (34): 
  Patients should be reminded that only they can decide to avoid the 
consequences that will occur without changes in drinking. The process of 
motivational interviewing has been summarized by the acronym 
FRAMES: Feedback to the patient; 
Responsibility to be taken by the patient;  
Advice, rather than orders, on what needs to be done;  
Menus of options that might be considered;  
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Empathy for understanding of the patient's thoughts and feelings; and  
Self-efficacy, i.e., offering support for the capacity of the patient to 
succeed in making changes. 
Both motivational interviewing and brief interventions can be 
carried out in 15-min sessions, but because patients do not always change 
behaviour right away, multiple meetings are often required to explain the 
problem, discuss optimal treatments, and explain the benefits of 
abstinence. 
Medication for rehabilitation (35): 
1. Naltrexone: opioid antagonist, acts by inhibiting activity of dopamine 
mediated reward system at ventral tegmental system; usual dose is 50–
150 mg/day or monthly preparation of 380mg (36). 
2. Acamprosate: acamprosate inhibits NMDA receptors, decreasing mild 
symptoms of protracted withdrawal. Dose is 2g/day in divided doses. 
Several trials of combined naltrexone and acamprosate using doses 
similar to those noted above have reported that the combination may be 
superior to either drug alone, although not all studies agree. 
3. Disulfiram:  an acetaldehyde dehydrogenase inhibitor. The drug itself 
carries potential risks of depression, psychotic symptoms, peripheral 
neuropathy, and liver damage.  
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4. Other drugs tried:  
Topiramate - anticonvulsant with effects on dopamine 
Ondansetron – serotonin antagonist 
Ramonibant - cannabinol receptor antagonist 
At present, there are insufficient data to support their use in clinical 
settings. 
Treatment of alcoholic neuropathy: 
In addition to Abstinence from alcohol, addiction counseling, and 
nutritionally balanced diet, neuropathic pain management usually begins 
with tricyclic antidepressants (TCAs) such as amitriptyline, imipramine, 
and desipramine, which can reduce burning, aching, sharp, throbbing and 
stinging (37). 
 Duloxetine hydrochloride, a dual reuptake inhibitor of serotonin 
and norepinephrine, is approved for the management of neuropathic pain. 
Tramadol is also effective for painful neuropathy.  
Anticonvulsants such as phenytoin, carbamazepine, clonazepam, 
gabapentin, topiramate, lamotrigine, and pregabalin are effective for 
lancinating pains.  
24 
 
Topical anesthetic agents including lidocaine, mexiletine, and 
capsaicin creams provide transient relief for focal neuropathic pain. 
Narcotics may be required for severe cases of refractory neuropathic pain. 
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MATERIALS & METHODS 
1. Place of study: Department of Neurology, Madras Medical 
College, Chennai - 600 003 
2. Type of Study: Cross sectional observational study 
3. Period of Study: March 2011 to December 2012 
4. Subject Selection:  Alcoholic patients referred to neurology 
outpatient clinic as well as those admitted in neurology ward with 
symptoms suggestive of neuropathy were included. 
MATERIALS 
Selected patients were subjected to detailed history, clinical 
examination, blood pressure, bed side autonomic function tests, blood 
sugar estimation, complete blood count including peripheral smear study, 
Liver Function Test (LFT) including serum albumin, and nerve 
conduction studies. 
Inclusion Criteria 
Alcoholic patients with symptoms suggestive of peripheral 
neuropathy. 
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Exclusion Criteria 
1. Patients with known case of diabetes /IGT. 
2. Patients with chronic renal failure. 
3. Patients with Liver disease/LFT abnormalities other than 
low albumin. 
4. Patients with malignancy. 
5. Patients on drugs known to cause peripheral neuropathy. 
6. Patients with a family h/o inherited neuropathies. 
7. Patients with h/o exposure to heavy metals and toxins. 
8. Patients with h/o lumbar or cervical radiculopathy. 
9. Patients with nutritional deficiencies. 
10. Patients with collagen vascular diseases. 
11. Patients with hypothyrodism, dysproteinemias, amyloidosis 
and AIDS.  
12. Age more than 50 years. 
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METHODOLOGY 
1. History with special emphasis on family history of alcoholism 
defined, as positive when one of the parents had history of alcohol 
abuse.  
2. Details regarding duration of alcohol exposure.  
3. A detailed history with screening for neuropathic symptoms.  
4. Symptoms and signs were analysed using Utah Early Neuropathy 
Scale (UENS) scoring system (38). 
5. Neurological examination including assessment of  motor power 
examination in lower and upper limbs, pain, temperature, ankle 
jerk,  and touch perception, timed vibration sense, position sense, 
Romberg's test, and presence of Postural hypotension 
 Sensory examination - the instruments used were (i) a disposable 
pin (ii) cotton tip (iii) a 128Hz tuning fork. 
6.    Small fiber neuropathy was diagnosed in the presence of pins & 
needle sensation and burning sensation   with autonomic symptoms 
whereas large fiber neuropathy was diagnosed in the presence of 
weakness, numbness and cotton wool sensation while walking with 
bare foot. 
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7. Electrodiagnosis  
 The RMS system with recommended filter settings was used for 
NCS.  
A. Motor NCS: 
 1. Median and ulnar nerves 
 2. Tibial and peroneal nerves  
 3. Computation of distal latency, calculation of segmental 
conduction velocity and amplitude of action potential was 
done in all stimulated nerves. 
 4. F Wave analysis (F minimum latency, F estimate) was done 
in all peripheral nerves. 
 5. H Reflex analysis 
B. Sensory NCS: 
 1. Ulnar and median nerves  
 2. Sural nerves in both lower limbs 
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 3. Computation of latency, amplitude and calculation of 
segmental Conduction velocity all done in all stimulated 
nerves 
C. Heart rate variability to deep respiration:  
  Heart variation to deep breathing was assessed by the 
technique as described by Shahani et al (1990). The patient was instructed 
to breath deeply at a rate of 6 per min (5 seconds for inspiration and 5 
seconds for expiration). E/I ratios were calculated as the ratio of 
maximum PR interval to minimum PR interval. 
 
Normal values by age for deep breath E/I ratio at different age: 
16 - 20 years = > 1.23, 21 - 25 years = > 1.20, 26 - 30 years = > 1.18, 31 - 
35 years = > 1.16, 36 - 40 years = > 1.14, 41 - 45 years = > 1.12, 46 - 50 
years = >1.11  
D. Sympathetic skin response: 
 Sympathetic skin response was recorded from the right palm and 
right sole using the method described by Shahani et al (1984). Standard 
surface electrodes were palced on the palm and dorsum of the right hand 
and sole and dorsum of the foot. 
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 A minimum of ten random stimuli were given at each site before 
considering the SSR to be absent. For the purpose of analysis, the absence 
of an elicitable SSR was considered as abnormal.      
The normal values representative for nerve conduction studies of 
various peripheral nerves were derived at after analysing the NCS of 50 
age matched normal persons (controls). 
Normal NCS value in age matched 50 controls 
Sensory studies  
SNAP'S AMP (µV) CV(m/s) 
Median >15 > 50 
Ulnar > 15 > 50 
Sural > 6 > 40 
 
Motor studies: 
CMAP'S DL (ms) Amp (mV) CV (m/s) 
F Wave lat 
(ms) 
Median <4 >5 >50 <31 
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Ulnar < 3.5 >5 >50 <31 
Tibial <6 >4 >40 <56 
Peroneal <6 >2 >40 <56 
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Results 
Table - 1:  Age and Sex  Distribution 
Age in years Number of patients Sex distribution 
       < 30 yrs 9  All patients are male 
        30 - 40 yrs 17 
        > 40 yrs 24 
         Total 50  
 
 
                           Table - 2: Family h/o alcoholism 
Positive Family history of 
alcoholism 
Number of patients 
Yes 19 
No 31 
Total 50 
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Table - 4: Nutritional Status 
Age in years BMI Sr.Albumin Hemoglobin 
Nor Low Nor Low Nor Low 
< 30yrs 8 1 8 1 7 2 
        30 - 40 yrs 14 3 13 4 14 3 
> 40 yrs 21 3 18 6 16 8 
Total 43 7 39 11 37 13 
                   
Out of 50 patients with alcoholic neuropathy, 7 patients have low 
BMI, defined as BMI <25. Among 7 patients with low BMI, 3 patients 
were above 40 years of age, 3 patients were aged between 30 to 40 years 
whereas 1 patient was below 30 years. 
11 patients out of 50 patients with alcoholic neuropathy had low 
serum albumin, defined as 3.5 grams/dl. Among 11 patients with low 
serum albumin, 1 patient was aged below 30 years, 4 patients were 
between 30 to 40 years and 6 patients were above 40 years of age. 
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   Table - 5: Sensory Symptoms 
         Out of 50 patients with alcoholic neuropathy, 41 patients had pins 
and needle sensation of the feet as their major sensory symptom, followed 
by burning sensation of their feet in 27 patients.. 
Symptoms Number 
Pins & needles sensation of feet 41 
Burning  feet 27 
Numbness of feet 19 
Hyperalgesia of feet 14 
Allodynia  8 
Unsteadiness in darkness 5 
 
 
Table – 6:  Sensory Symptom  
Type of sensory symptom Yes No 
Positive 46 4 
Negative 23 27 
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46 patients out of 50 patients with alcoholic neuropathy presented 
with positive sensory symptoms whereas only 23 patients had negative 
sensory symptoms. 
Table – 7: Autonomic Symptoms 
Symptoms Percentage 
Erectile dysfunction 26% 
Sweating disturbances 12% 
Postural Giddiness 8% 
Bladder disturbances 2% 
 
Out of 50 patients with alcoholic neuropathy, most common 
autonomic symptom was erectile dysfunction which was noted in 13 
patients, followed by sweating disturbances in 6 patients. Out of 13 
patients with erectile dysfunction, they present either loss of erection or 
diificulty in sustaining erection. 
4 patients have postural giddiness and 1 patient had bladder 
disturbances. 
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   Table – 9:  DTR (Upper Limb)  
 
DTR Response Number Percentage 
Normal 42 84% 
Sluggish 5 10% 
Absent 3 6% 
Out of 50 patients with alcoholic neuropathy, 42 patients had normal 
upper limb deep tendon reflexes whereas 8 patients had hypo or areflexia 
in the upper limbs. 
 Table – 10: DTR (Lower limb)  
 
DTR Response Number Percentage 
Normal 24 48% 
Sluggish 17 34% 
Absent 9 18% 
Out of 50 patients with alcoholic neuropathy, 34 patients had normal 
lower limb deep tendon reflexes whereas 16 patients had hypo or 
areflexia in the lower limbs.           
      Table -11: Clinical Diagnosis 
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Clinical Diagnosis No. of patient 
Sensory Neuropathy 28 
Sensorimotor Neuropathy 9 
Motor  Neuropathy 0 
Autonomic  Neuropathy 0 
Sensroy + Autonomic  Neuropathy 10 
Sensorimotor + Autonomic neuropathy 3 
                  Total 50 
 
 Out of 50 patients with alcoholic neuropathy, 28 patients presented 
with sensory neuropathy, 9 patients with sensorimotor neuropathy, 10 
patients with sensory and autonomic neuropathy, and 3 patients with 
sensorimotor with autonomic neuropathy. All neuropathy patients had 
features suggestive distal symmetrical polyneuropathy either sensory 
predominant or sensorimotor neuropathy.   No patient had pure motor or 
autonomic neuropathy. 
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                   Table -13: UENS Score Vs Age 
 Age No of Patients Mean Score 
Age < 30 yrs 9 21.4 
Age 30 -40 yrs 17 26.7 
Age >40yrs 24 33.2 
                             Mean score  28.8 
 
 Out of 50 patients with alcoholic neuropathy, 9 patients with age 
less than 30 years had mean UENS Score of 21.4, 17 patients in 30 – 40 
years of age  had mean UENS Score of 26.7 and rest of 24 patients with 
age of above 40 years had mean UENS Scale Score of 33.2. 
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      Table -15:  UENS Scores Vs Autonomic Symtoms 
UENS No of Patients with 
Autonomic symp. 
Mean Score 
< 20 0 0 
20 - 25 1 24 
25 – 30 4 29.8 
> 35 8 34.4 
Total patients 13  32.1 
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Table -16:  UENS Scores Vs Autonomic Symtoms 
 No. Of patients  
 (N = 50) 
Mean UENS Score 
Patients with 
Autonomic symptoms 
13 32.1 
Patients without 
Autonomic symptoms 
37 27.6 
 
 
 
              Table –17: Upper Limb CMAP  
Median  Normal Abnormal ( 
Reduced CMAP) 
Total 
     Right 46 4 50 
     Left 46 4 50 
Ulnar     
     Right 46 4 50 
     Left 46 4 50 
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4 patients out of 50 patients had abnormal CMAPs (Compound Muscle 
Action Potential) in the form of  reduced CMAPs in the upper limb motor 
nerves like Median and Ulnar nerves. Nerve conduction velocity and 
latency were normal.  
Table –18: Lower Limb CMAP  
Tibial Normal Abnormal Total 
     Right 36 14 50 
     Left 36 14 50 
Peroneal     
     Right 36 14 50 
     Left 36 14 50 
 
14 patients out of 50 patients had abnormal CMAPs (Compound Muscle 
Action Potential) in the form of reduced CMAPs. Nerve conduction 
velocity and motor latency were normal 
 Table –19: Upper Limb SNAP 
Median  Normal Abnormal Total 
     Right 43 7 50 
     Left 43 7 50 
Ulnar     
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     Right 43 7 50 
     Left 43 7 50 
 
7 patients out of 50 patients had abnormal SNAPs (Sensory Nerve Action 
Potential) in the form of reduced SNAPs in the upper limb nerves like 
Median and Ulnar nerves. 
Table –20: Lower Limb SNAP  
Sural Normal Abnormal Total 
     Right 13 
 
37 50 
     Left 13 37 50 
 
13 patients out of 50 patients had abnormal SNAPs (Sensory Nerve 
Action Potential) in the form of  reduced SNAPs in the lowerr limb nerve. 
Table -21:  H reflex  
Response  Yes 
Normal 21 
Abnormal 29 
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Out of 50 patients with alcoholic neuropathy, 21 patients had abnormalt 
H reflex. 
 
TABLE - 22  NCS Vs UENS score 
 
 
 No. Of patients 
 (N= 50) 
Mean UENS Score 
Patients with Abnormal NCS 37 29.7 
Patients with normal NCS 13 26.2 
 
 
 
 
Table – 23:  HRV 
Response  No. of patients (N= 50) 
Normal response 35 
Abnormal response 15 
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Table – 24:  Postural Hypotension 
Response No. of patients (N= 50) 
Present 9 
Absent 41 
   
  Table – 25: Sympathetic Skin Response  
Stimulation 
Site 
                                    Recording site 
                Palm                    Sole 
SSR   
Normal 
SSR  
abnormal 
SSR  Normal SSR 
Abnormal
Median N. 44 6 40 10 
Post. Tibial 40 10 36 14 
Table 26: Clinical Symptoms Vs NCS 
abnormality 
Out of 50 patients with alcoholic neuropathy, based on symptoms, 37 
patients had abnormal NCS. Rest of the 13 patients had normal NCS 
study. 
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Duration of alcohol 
exposure 
No. Of patients with  
Abnormal  NCS 
No. Of patients 
with  Normal  NCS 
Less than 5yrs 1 9 
5 to 10 yrs 10 3 
More 10 yrs 26 1 
Total 37 13 
 
Statistical analysis:  
  
In this study Pearson chi-square test was used for comparison. 
UENS Score was compared to age, duration of alcohol exposure, 
autonomic symptoms and NCS abnormalities and statistical significance 
was calculated. As age , duration of alcohol exposure and NCS 
abnormalities were associated with higher UENS score, suggesting of 
severe form of peripheral neuropathy.  
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Table 27: Statistical analysis:  
 
 CHI SQUARE VALUE  P VALUE 
UENS Score Vs Age 21.645  < 0.005 (Significant) 
UENS Score Vs Duration of 
alcohol abuse 
18.827  < 0.005 (Significant) 
UENS Score Vs NCS 
abnormalities 
11.574 < 0.005 (Significant)
UENS Score Vs Autonomic  
symptoms 
4.198  > 0.005 (Insignificant) 
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DISCUSSION 
In our study, it was found that among 50 patients with alcoholic 
neuropathy, 9 patients had age less 30 years, 17 patients had age between 
30 - 40 years and rest of the 24 patients had age more than 40 years. 
There was a good correlation between age and incidence of alcoholic 
neuropathy. 
Giovanni vittadini et al (39) in their clinical and epidemiological 
series showed that subjective symptoms and sign were increased 
significantly with age. In their study of 48 alcoholic neuropathic patients, 
they noticed that after the age of 40 years, incidence of polyneuropathy 
increases significantly due to alcohol exposure. 
Behese and Buchtal et al, 1997 and Wetterling et al, 1999 also 
showed that duration of alcohol abuse was the most important factor in 
the development of polyneuropathy.  
In our study, all patients were male; because the prevalence of 
alcohol abuse in women was less in our part of country. In a similar study 
by A Ammendola et al, out of 62 patients, majority of patients were male.  
Giovanni vittadini et al (39) observed that more than 70% of alcoholic 
neuropathic in their series were male. 
54 
 
19 out of 50 patients with alcoholic neuropathy in our study had 
positive family history of alcohol abuse. Incidence of alcoholic 
neuropathy increases in patients with positive family history of alcohol 
abuse; and also the effects of alcoholism and abusive tendency were 
increased in these patients. Hrubec Z et al (40) showed increased incidence 
of alcohol abuse and alcohol related end organ damage like neuropathy in 
family, presents which was probably due to a genetic predisposition.  
Mean duration of alcohol exposure increases as age increases in 
patients with alcoholic neuropathy. In our study, 9 patients with age less 
than 30 years, had alcohol exposure of 5.9 years, 17 patients with age 
between 30 - 40 years had alcohol exposure of 9.6 years whereas 24 
patients age more than 40 years patients had alcohol exposure of 16.3 
years. 
In an alcoholic epidemiological study, Giovanni vittadini et al 
concluded that duration of alcohol intake was one of the important factor 
in the development of alcoholic neuropathy. They showed that 
development of neuropathic symptoms need minimum of 5 years of 
alcohol intake whereas severe polyneuropathy needs at least 10 years of 
alcohol intake.   
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Thomas Zambelis et al (41) in their series of 57 alcoholic neuropathy 
showed that alcoholic neuropathy correlated with duration of alcohol 
abuse. 
Most common sensory symptom in patients with alcoholic 
neuropathy in our series was pins and needles followed by burning 
sensation of the both feet. These symptoms are suggesting of small fiber 
predominant neuropathy. Predominantly they had positive sensory 
symptoms. 
In a study by H. Koike MD et al (42) alcoholic neuropathy patients 
had, predominantly abnormal sensory symptoms in the form of burning 
sensation in the lower limbs as their first symptoms. 
In our study, 13 patients had autonomic neuropathic symptoms in 
addition to peripheral neuropathy. Most common autonomic symptoms 
were erectile dysfunction (13 out of 50 patients) followed by sweating 
abnormalities (6 patients).  
In the autonomic function tests, HRV (Heart Rate Variability) to 
deep breathing, 15 patients had abnormal HRV ratio to deep breathing.  9 
patients out of 50 patients had abnormal fall in the standing blood 
pressure that is postural hypotension and 14 patients had abnormal SSR 
(sympathetic skin response); while clinical symptoms of autonomic 
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neuropathy observed only in 13 patients, autonomic function tests showed 
autonomic fiber involvement in 15 patients. 
In our study, 2 patients had objective autonomic signs before 
development of subjective symptoms. In our series, only one fourth of 
alcoholic neuropathy patients had autonomic symptoms and it showed 
that there is no parallel involvement of somatic and autonomic fibers in 
alcoholic neuropathy. Subclinical autonomic neuropathy was common in 
alcoholic neuropathy and these patients should be screened for autonomic 
dysfunction even in the absence of subjective autonomic symptoms. 
Since autonomic dysfunction occurs early on in the disease before 
symptoms and signs of peripheral neuropathy occur, screening bedside 
autonomic function tests should be done in all patients with alcoholic 
neuropathy.  
C. Nicolosi et al (43) had similar findings; in their study, one sixth of 
alcoholic neuropathy had autonomic involvement and there was no 
statistical correlation between severity of alcoholic somatic neuropathy 
and autonomic neuropathy.  
In a study by M.W. Agelinka (44) et al, 40% of alcoholic neuropathy 
patients had autonomic neuropathy in the form of abnormal HRV to deep 
57 
 
inspiration and sustained hand grip. In their study, no patients had 
isolated autonomic neuropathy without peripheral neuropathy.  
Roser Monforte et al (45), in their series noted autonomic 
neuropathy in 24.3% patients and the duration of alcohol exposure 
correlated to autonomic neuropathy.   
Only 12 patients out of 50 had motor weakness in lower limbs in 
our series. 
In our study, majority of patients (56%) had sensory neuropathy 
and rest of the patients presented with combinations of motor, sensory 
and autonomic neuropathy. 
 Out of 50 patients with alcoholic neuropathy, 25 patients had 
clinically both large and small fiber involvement, 15 patients had small 
fiber involvement whereas 9 patients had clinically large fiber 
involvement.  
 In a study by Thomas Zambelis et al (41), out of 57 chronic 
alcoholics, 25 patients had features of both large and small fiber 
neuropathy, whereas 20 patients had large fiber involvement only and 
rest of the 12 patients had small fiber involvement. 
 Utah Early Neuropathy Scale Score is used to assess small fiber 
predominant neuropathies. In our study, Out of 50 patients with alcoholic 
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neuropathy, 9 patients with age < 30 years had mean Utah Early 
Neuropathy Scale Score of 21.4, 17 patients had mean Utah Early 
Neuropathy Scale Score of 26.7 and rest of 24 patients with age of above 
40 years had mean Utah Early Neuropathy Scale Score of 33.2. As age 
increases, Utah Early Neuropathy Scale (UENS) Score increases in our 
study with statistically significant P value. 
  Out of 50 patients with alcoholic neuropathy, 10 patients had 
mean duration of alcohol abuse of less than 5 yrs with mean Utah Early 
Neuropathy Scale Score of 22.7; 13 patients had mean duration of alcohol 
exposure of 5 - 10 yrs with mean Utah Early Neuropathy Scale Score of 
26.5 whereas 27 patients had mean duration of alcohol exposure of more 
than 10 yrs with mean Utah Early Neuropathy Scale Score of 32.2. As 
duration of alcohol abuse increases, Utah Early Neuropathy Scale 
(UENS) Score increases with statistically significant P value. 
Out of 50 alcoholic neuropathic patients, 4 patients had abnormal 
motor conduction in the upper limbs and 14 in the lower limbs patients in 
the form of reduced / absent compound motor action potential. 
In the sensory conduction, 8 out of 50 patients in the upper limbs 
and 37 patients in the lower limbs had abnormal conduction in the form 
of axonopathy. Nerve conduction velocity, latency and F wave studies 
were normal in all 50 patients. 13 patients with alcoholic neuropathy had 
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normal conduction with any out electrophysiological evidence of nerve 
fiber involvement. We found that 13 of our patients with symptomatic 
neuropathy had normal NCS findings; this discordance is due to the 
earlier involvement of small fibers in patients with alcohol abuse which is 
not detected in routine NCS. 
Discordance between symptoms of peripheral neuropathy and 
findings on nerve conduction studies had been reported before by 
Sangiorgio et al., and Fedele et al. 
In a study by A ammendola et al (46), alcoholic neuropathic patient 
had axonal form in their nerve conduction studies. 
In a study by Thomas Zambelis et al (41) all the 42 alcoholic 
neuropathic patients showed axonal form in electrophysiological exam. 
In a study by Matti hillbom et al (47) over 24 alcoholic neuropathic 
patients, all the patient presented with length dependent neuropathy and 
electro physiologically axonal changes.  
In a study by John P Ballantyne et al (48), alcoholic neuropathic 
patients had predominantly axonal changes in nerve conduction studies. 
In their study of 31 alcoholic neuropathy patients, both motor and sensory 
nerves showed axonal changes. In contrast to our study, in their study, 
there was no preferential sensory fiber involvement. 
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In a study by Kimura et al (30), nerve conduction studies in alcohol 
neuropathic patients had shown axonal changes with preferable involving 
sensory fibers especially in lower limbs which were similar to our studies. 
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Conclusion 
 The following conclusions were made in our study of 50 patients of 
alcohol neuropathy: 
1. Prolonged duration of alcohol intake and increasing age were 
associated with more severe form of peripheral neuropathy in 
alcoholic patients.  
2. Distal symmetrical polyneuropathy was the commonest mode of 
presentation of alcohol neuropathy.   
3. Most common presenting symptom was pins and needle sensation of 
both feet. 
4. Alcoholic peripheral neuropathy was primarily a painful sensory 
neuropathy. 
5. Discordance between neuropathic symptoms and NCS was found to 
occur in one fourth of patients.  
6. One fourth of alcoholic neuropathic patients had autonomic features. 
7. Erectile dysfunction was the most common autonomic symptom in 
alcoholic neuropathy. 
8. Two patients were found to have subclinical autonomic neuropathy. 
9.  There was no parallel involvement of somatic and autonomic fibers in 
alcoholic neuropathy. 
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Proforma: 
Name 
Age / sex 
Duration 
Symptoms 
  Motor 
  Sensory 
  Autonomic 
Family h/o 
Duration of alcohol intake  
BMI 
 
Screening for other causes of neuropathy  
UENS Score 
 
SMS: 
Weakness 
DTR  
Sensory system: 
  STT Sensation 
71 
 
  PC sensation 
Autonomic signs 
  Skin/nail changes 
  Postural Hypotension 
Other neurological signs 
UENS Score 
CBC 
  Hb 
  PS study 
RFT 
  Creatinine 
  Urea 
FBS , PPBS 
HIV & VDRL 
LFT 
  Albumin 
Autonomic Funtion test 
HRV 
SSR 
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Sensory studies  
SNAP'S  Latency  AMP (µV)  CV(m/s) 
Median Rt       
Median Lt       
Ulnar Rt       
Ulnar Lt       
Sural Rt       
Sural Lt       
 
Motor studies: 
Median Rt  DML DA PA NCV F latency
Median Lt     
Ulnar Rt    
Ulnar Lt           
Tibial Rt    
Tibial Lt     
Peroneal  Rt     
Peroneal Lt     
 
H reflex: 
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ABBREVIATIONS: 
AFT ‐ Autonomic Function Test 
AMP ‐ Amplitude 
BF ‐ Burning Sensation of the feet 
Blad ‐ Bladder Disturbances 
BMI ‐ Body Mass Index 
CMAP‐ Compound Muscle Action Potential 
CV ‐ Conduction Velocity 
DL ‐ Distal Latency 
ED ‐ Erectile Dysfunction 
E/I ratio ‐ Expiration / Inspiration ratio 
DSM‐IV‐T ‐ Diagnostic and Statistical Manual of Mental Disorders – IV –
Text Revision 
DTR ‐ Deep Tendon Reflex 
Hb – Hemoglobin 
HRV ‐ Heart Rate Variability 
Hyper ‐ Hyperesthesia 
H/O ‐ History Of 
IGT ‐ Impaired Glucose Tolerance test 
JPS ‐ Joint Position Test 
LFT ‐ Liver Function Test 
LL ‐ Lower Limb 
m/s – metre/second 
NCS ‐ Nerve Conduction Studies 
74 
 
NF – Numbness of the feet 
NMDA ‐ N Methyl D asparate 
Po. ‐ Positive Symptoms 
PN ‐ Postive and Negative Symptoms 
Post. Giddiness ‐ Postural Giddiness 
PNS ‐ Peripheral Nervous System 
P & N – Pins and Needle 
PR ‐ Pulse Rate 
SN ‐ Sensory Neuropathy 
SAN ‐ Sensory Autonomic Neuropathy 
SMN ‐ Sensory Motor Neuropathy 
SMAN ‐ Sensory Motor Autonomic Neuropathy 
SNAP ‐ Sensory Nerve Action Potential 
Sr. ‐ Serum 
TCA ‐ Tricyclic Antidepressants 
UENS Score ‐ Utah Early Neuropathy Scale Score 
UL ‐ Upper Limb 
 
 
 
 
 
Pt No. Age
Family 
h/o Sex
Duration of 
alcohol 
exposure BMI P & N BF NF Hyper Allodynia Unstead Symptoms ED Sweating
Post. 
Gidd Blad
Big toe 
weakness LL DTR
1 26 No M 4.5 N P P P A A A Po A A A A N N
2 27 Yes M 5 N P A A A A A Po A A A A N N
3 29 No M 9.5 Low P P A P P A PN A A A A N N
4 28 No M 5 N A A P A A A Po P A A A W N
5 29 No M 5 N P P A A A A Po A A A A N S
6 30 Yes M 4 N P A A A A A PN A A A A N N
7 26 No M 5 N P P A A A A Po A A A A N N
8 28 No M 10 N P A P A A A PN A A A A W A
9 25 Yes M 5 N P P A P P A Po A A A A N N
10 35 No M 9 N P A P A A A PN P A A A N S
11 38 No M 15 N P P A A A A Po A A A A N N
12 34 Yes M 20 N P P A A A A PN A P A A N S
13 33 No M 17 Low A A P A A P Po P A A A W A
14 39 Yes M 5 N P A A A A A Po A A A A N S
15 32 No M 8 N P P P P A A Po A A A A N S
16 37 No M 9 N P A A A A A PN A A A A N N
17 35 No M 18 N P P A P A A Po A A A A N S
18 39 Yes M 9 Low A A P A A P PN P A A A W A
19 40 No M 10 N P P P A A A Po A P A A N N
20 34 No M 9 Low P A A A A A Po P A P A N N
21 32 Yes M 5 N P P P P P A PN A A A A N S
22 39 No M 18 N P A A A A A Po A A A A N N
23 31 No M 10 N A P P A A P Po P A A A W A
24 36 Yes M 5 N P A A A A A PN A A A A N N
25 33 No M 10 N P P P A A A Po A A A P N S
 M ‐ Male     
A ‐Absent
Po ‐ positive Ne ‐ Negative SAN ‐ Sensory Autonomic neuropathy SMN ‐ Sensory Motor Neuropathy
SMAN ‐ Sensory Motor Autonomic Neuropathy
S ‐ Small fiber 
L ‐ Large fiber 
LS ‐ Large small fiber
P ‐ Present Ab. ‐ Abnormal
PN ‐ Positive & Negative 
S‐ Sluggish SN ‐ Sensory neuropathy
UL DTR Diagnosis
Fiber 
type UENSS UL CMAP UL SNAP LL CMAP
Sural 
SNAP H reflex HRV
Postural 
hypotens
ion SSR Hb Albumin
N SN LS 22 N N N A N N N N N N
N SN S 16 N N N N N N N N N N
N SN LS 24 N N N A N N N N Low Low
N SMN L 26 N N A A A N N N N N
N SN LS 20 N N N A N N N N N N
N SN S 30 N N N N N N N N N N
N SN LS 20 N N N A N N N N N Low
N SMN L 18 N N A A A N N N N N
N SN LS 17 N N N A N N N N N N
N SAN LS 22 N N N A A Ab. N A N N
N SN S 28 N N N N N N N N N N
N SN LS 32 N N N A N N N N N N
N SMN L 26 N N A A A N N N Low Low
N SN LS 22 N N N A N N N N N N
N SAN LS 26 N N N A N Ab. P A N N
N SN S 28 N N N N N N N N N N
N SAN LS 32 N N N A N Ab. N A N Low
N SMN L 26 N N A A A N N N Low N
N SAN LS 32 N N N A N Ab. P A N N
N SN S 24 N N N N N N N N N N
S SAN LS 22 N N N A A Ab. N A Low N
N SN S 24 N N N N N N N N N Low
A SMN LS 30 N N A A A N N N N N
N SN S 22 N N N N N N N N N N
N SAN LS 24 N N A A A Ab. P A Low Low
Pt No. Age
Family 
h/o Sex
Duration 
of alcohol 
exposure BMI P & N BF NF Hyper Allodynia Unstead. Symptoms ED Sweating Post. Gidd Blad
Big toe 
weakness LL DTR
26 37 Yes M 20 N P A A A A A PN A P A A N N
27 42 No M 15 N P P P A A A Po P A A A W S
28 46 No M 16 N P A A A A A PN A A A A N N
29 49 Yes M 18 Low P P A P P A Po P A P A N N
30 41 No M 8 N P A A A A A Po A A A A N N
31 43 Yes M 20 N A A P A A A Ne A P A A W A
32 48 No M 17 N P P A P P A PN A A A A N S
33 47 Yes M 15 Low A A P A A A Ne P A A A W S
34 48 No M 17 N P P A P A A Po A P A A N N
35 43 Yes M 15 N A A P A A P PN A A A A W A
36 47 No M 20 N P P A P P A PN A A A A N N
37 43 No M 18 N P A P A A A Po P A A A N S
38 42 Yes M 8 N P P A P A A PN A A A A N N
39 43 No M 19 N P P A A A A Po A A A A N S
40 45 Yes M 20 N A A P A A P Ne P A P A W A
41 44 Yes M 18 N P P A P A A Po A P A A N N
42 47 No M 8 N P A P A A A PN A A A A W A
43 41 No M 12 N P P A A A A Po A A A A N N
44 45 No M 15 N P P A P P A PN P A A A N S
45 42 Yes M 18 N P A A A A A PN A A A A N S
46 49 No M 15 Low P P A A A A Po A P A A N N
47 44 No M 20 N P P A P P A Po A A P A N S
48 43 No M 17 N P P A A A A PN P A A A N N
49 48 No M 25 N A A P A A A Ne A A A A W A
50 45 Yes M 18 N P P A P A A PN A A A A N S
UL DTR Diagnosis Fiber type UENSS UL CMAP UL SNAP LL CMAP
Sural 
SNAP H reflex HRV
Postural 
Hypotensi
on SSR Hb Albumin
N SN LS 34 N N N A N N N N N N
S SMN L 34 N A A A A N N N N N
N SN S 36 N N N N N N N N N N
N SAN LS 34 N N N A A Ab. N A Low Low
N SN LS 30 N N N A N N N N N N
N SMN L 38 N N A A A N N N N N
N SN LS 34 N N N A N N N N N N
S SMAN L 28 N A N A A Ab. P A Low Low
N SN S 30 N N N N N N N N N N
N SMN LS 24 A A A A A N N N N N
N SN S 36 N N N N N N N N N N
S SAN LS 40 N N A A A Ab. P A Low Low
N SN S 28 N N N N N N N N N N
N SN LS 32 N N N A A N N N N Low
A SMN L 36 A A A A A N N N N N
N SN S 34 N N N A N N N N N N
N SMAN LS 32 A A A A A Ab. P A Low Low
N SN S 30 N N N N N N N N N N
N SAN LS 32 N N N A N Ab. P A N N
S SN LS 34 N A A A A N N N N N
N SN S 32 N N N N N Ab. P N Low Low
N SAN LS 36 N N N A A Ab. P A N N
N SN S 32 N N N A N N N N N N
A SMAN L 44 A A A A A Ab. N A N Low
N SN LS 32 N N N A A Ab. N N Low N
